
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
Keywords: Lrrk2; Parkinson's disease; Dopamine; Electrophysiology; Mouse model; eCB; endocannabinoids; G2019S; glycine to serine substitution at amino acid 2019; KD; kinase-dead; Lrrk2; leucine-rich repeat kinase2; Sulp; l-sulpiride; SPN; spiny projection neuron; P